Top compounds associated with response to SLC39A1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.034 0.3
mRNA EX-527 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.029 0.3
mRNA lomeguatrib CTRPv2 pan-cancer AAC -0.037 0.3
mRNA MS-275 GDSC1000 pan-cancer AAC -0.056 0.3
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.033 0.3
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC 0.037 0.3
Download CSV